Gustavo Pacheco-Rodriguez Selected Research

Gustavo Pacheco-Rodriguez Research Topics

Disease

27	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2022 - 03/2002
19	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 03/2002
17	Neoplasms (Cancer) 01/2021 - 09/2005
8	Angiomyolipoma 01/2018 - 12/2004
7	Lung Diseases (Lung Disease) 01/2022 - 12/2004
5	Disease Progression 01/2019 - 07/2010
5	Lymphangiomyoma 03/2015 - 12/2009
4	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2007
4	Pleural Effusion (Pleural Effusions) 01/2018 - 11/2007
3	Cysts 03/2010 - 07/2006
2	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 03/2002
2	Carcinogenesis 01/2017 - 09/2005
2	Leiomyoma (Uterine Fibroids) 09/2013 - 03/2010
2	Pneumothorax 08/2010 - 03/2010
2	Hamartoma 03/2010 - 03/2008
2	Melanoma (Melanoma, Malignant) 01/2010 - 02/2009
2	Fibroma (Fibromatosis) 03/2008 - 09/2005
2	Angiofibroma 03/2008 - 09/2005
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Rare Diseases (Rare Disease) 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Idiopathic Pulmonary Fibrosis 07/2014
1	Adenocarcinoma of Lung 09/2013
1	Hypoxia (Hypoxemia) 01/2011
1	Dyspnea (Shortness of Breath) 03/2010
1	Chylothorax 03/2010
1	Hemorrhage 03/2010
1	Lymphadenopathy 12/2009
1	Breast Neoplasms (Breast Cancer) 02/2009
1	Chylous Ascites 11/2007
1	Fibrosis (Cirrhosis) 09/2005
1	Adenocarcinoma 09/2005
1	Lymphatic Abnormalities 12/2004

Drug/Important Bio-Agent (IBA)

22	lipoarabinomannan (LAM)IBA 01/2022 - 03/2002
16	trans-sodium crocetinate (crocetin)IBA 01/2021 - 12/2004
6	Sirolimus (Rapamycin)FDA Link 01/2021 - 09/2005
4	Vascular Endothelial Growth Factor DIBA 01/2021 - 12/2009
3	Tuberous Sclerosis Complex 2 ProteinIBA 01/2011 - 09/2005
3	Messenger RNA (mRNA)IBA 08/2010 - 09/2005
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 08/2010
2	ChemokinesIBA 01/2010 - 02/2009
2	TOR Serine-Threonine KinasesIBA 03/2008 - 07/2006
2	Tuberous Sclerosis Complex 1 ProteinIBA 11/2007 - 09/2005
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Methacholine Chloride (Methacholine)FDA Link 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	ReninIBA 01/2019
1	AngiotensinsIBA 01/2019
1	AntigensIBA 01/2018
1	Bronchodilator Agents (Bronchodilators)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Syk KinaseIBA 01/2017
1	Melanoma-Specific AntigensIBA 03/2015
1	Hormones (Hormone)IBA 09/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013
1	OsteoprotegerinIBA 09/2013
1	MitogensIBA 01/2011
1	Erythropoietin FDA Link 01/2011
1	ProlactinIBA 08/2010
1	Prolactin Receptors (Prolactin Receptor)IBA 08/2010
1	Estrogens (Estrogen)FDA Link 07/2010
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2010
1	Chemokine ReceptorsIBA 01/2010
1	EpiregulinIBA 03/2008
1	Hyaluronic Acid (Hyaluronan)IBA 11/2007
1	Conditioned Culture MediaIBA 09/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2005
1	LY 303511IBA 09/2005

Therapy/Procedure

2	Therapeutics 01/2018 - 07/2010
2	Lung Transplantation 04/2015 - 12/2004